In2Bones Introduces CoLink® Mfx Midfoot Plating System

Addressing Midfoot Surgery Challenges with Innovative Lisfranc Plates And Novel Cross-Joint Compression

September 8, 2021

MEMPHIS, Tenn.–(BUSINESS WIRE)–In2Bones Global, Inc. today announces the U.S. launch of its CoLink® Mfx Midfoot Plating System. This versatile collection of low-profile plates is designed to address various traumatic fractures, osteotomies and fusions of the midfoot.

The new fixation system includes eight titanium plate styles for Lisfranc and midfoot procedures, together with variable angle locking, fixed-locking, non-locking and cancellous screws, and full instrumentation for guided use.

Accommodating the anatomy of the first tarsometatarsal joint, the Lisfranc Plates feature a unique dorsal to plantar twist during the transition from the proximal to distal screw holes, allowing room for an independent homerun screw to be placed.

“The challenges with previous fixation systems is that they don’t take into account the anatomic structure of the medial cuneiform bone,” says Kevin Varner, MD, Chairman of the Department of Orthopedics, Houston Methodist Weill Cornell Medical College, and Specialist at Houston Methodist Orthopedics and Sports Medicine. “The twist in the CoLink Mfx Lisfranc plate allows me to more easily capture better bone in the medial cuneiform while avoiding the intercuneiform joint, and provides room for the homerun Lisfranc screw.”

The Midfoot Reconstruction family of plates also feature a low-profile, dynamic transverse compression hole for use with a 4.0mm CoLag® Screw for compression across the joint or fracture location.

The entire fixation system is delivered pre-sterilized and OR-ready, providing logistical, quality, and cost benefits to the healthcare provider.

Plate Design Improvements

Like all In2Bones products, the CoLink Mfx Midfoot Plating System features numerous design enhancements to simplify and speed the surgical procedure and improve patient outcomes, including:

  • Low-profile, anatomically contoured titanium plates are designed to fit patient anatomy.
  • A Type II anodization finish is intended to give CoLink Mfx plates a stronger, smoother surface than standard color anodization.
  • Minimal prominence at the plate and screw head interface may provide additional protection against soft tissue irritation.

For more information about the new CoLink Mfx Midfoot Plating System and other In2Bones Global, Inc. extremity products, please visit www.in2bones.com.

About In2Bones

Headquartered in Memphis, Tennessee, In2Bones is a global designer, manufacturer and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. For more information, visit www.in2bones.com.

Safe-Harbor Statement:

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management’s current view of future performance, results, and trends and may be identified by their use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “will,” and other similar terms. The company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties impacting the business, including increased competition, technical obsolescence, regulatory issues, general economic conditions and other risks.


Media Contacts:
Jon Simon, Executive Vice President of Marketing
In2Bones USA
6000 Poplar Ave, Suite 115 Memphis, TN 38119

Bob Reed
Element-R Partners

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button